XML 30 R13.htm IDEA: XBRL DOCUMENT
v3.25.3

FAIR VALUE | 12 Months Ended
--- | ---
Oct. 03, 2025
Fair Value Disclosures [Abstract] |
FAIR VALUE | FAIR VALUE Assets and Liabilities Measured at Fair Value on a Recurring Basis The fair values of certain of the Company’s financial instruments, including bank deposits included in cash and cash equivalents, accounts receivable, net and accounts payable, approximate their fair values due to their short maturities. The fair values of the Company’s Senior Secured Notes, as defined in Note 6, Borrowings and measured using Level 1 inputs, and as of October 3, 2025 and September 27, 2024 was $375.8 million and $247.6 million respectively. The Company has elected to use the income approach to value its derivative instruments using standard valuation techniques and Level 2 inputs, such as currency spot rates, forward points and credit default swap spreads. In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.
| Fair Value at October 3, 2025
(In millions) | Quoted Prices in Active Markets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3) |  | Total
Assets: |  |  |  |  |  |  |
Commercial paper | $ | — |  |  | $ | 2.0 |  |  | $ | — |  |  | $ | 2.0 |
Corporate notes/bonds | — |  |  | 4.0 |  |  | — |  |  | 4.0 |
Government agencies | — |  |  | 2.0 |  |  | — |  |  | 2.0 |
U.S. treasury bills | — |  |  | 15.8 |  |  | — |  |  | 15.8 |
Deferred compensation plan(1) | 8.4 |  |  | — |  |  | — |  |  | 8.4 |
Marketable equity securities | 3.6 |  |  | — |  |  | — |  |  | 3.6 |
Total assets measured at fair value | $ | 12.0 |  |  | $ | 23.8 |  |  | $ | — |  |  | $ | 35.8 |
Liabilities: |  |  |  |  |  |  |
Derivative liabilities | $ | — |  |  | $ | 10.4 |  |  | $ | — |  |  | $ | 10.4 |
Total liabilities measured at fair value | $ | — |  |  | $ | 10.4 |  |  | $ | — |  |  | $ | 10.4 |
(1) The assets held under the Company’s deferred compensation plan are classified in Level 1, as they relate primarily to publicly traded mutual funds for which there are observable market prices in active markets.
| Fair Value at September 27, 2024
(In millions) | Quoted Prices in Active Markets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3) |  | Total
Assets: |  |  |  |  |  |  |
Money market funds | $ | — |  |  | $ | 24.4 |  |  | $ | — |  |  | $ | 24.4 |
Corporate notes/bonds | — |  |  | 16.5 |  |  | — |  |  | 16.5 |
Government agencies | — |  |  | 18.3 |  |  | — |  |  | 18.3 |
U.S. treasury bills | — |  |  | 6.1 |  |  | — |  |  | 6.1 |
Certificates of deposit | — |  |  | 0.9 |  |  | — |  |  | 0.9 |
Derivative assets | — |  |  | 1.0 |  |  | — |  |  | 1.0 |
Deferred compensation plan(1) | 7.5 |  |  | — |  |  | — |  |  | 7.5 |
Marketable equity securities | 2.6 |  |  | — |  |  | — |  |  | 2.6 |
Total assets measured at fair value | $ | 10.1 |  |  | $ | 67.2 |  |  | $ | — |  |  | $ | 77.3 |
Liabilities: |  |  |  |  |  |  |
Derivative liabilities | $ | — |  |  | $ | 8.6 |  |  | $ | — |  |  | $ | 8.6 |
Total liabilities measured at fair value | $ | — |  |  | $ | 8.6 |  |  | $ | — |  |  | $ | 8.6 |
(1) The assets held under the Company’s deferred compensation plan are classified in Level 1, as they relate primarily to publicly traded mutual funds for which there are observable market prices in active markets. Nonrecurring Fair Value Measurements During fiscal year 2025, the Company assessed its goodwill for impairment and concluded that the carrying value of the Medical reporting unit was greater than its fair value. The nonrecurring fair value measurements used by the Company to determine the impairment of the Medical reporting unit goodwill was calculated by equal weighting of the income approach based on estimated discounted future cash flows and the market approach based on comparable publicly traded companies in similar lines of businesses. Under the income approach, fair value is determined based on a discounted cash flow technique that uses estimates of cash flows discounted to present value using rates commensurate with the risks associated with those cash flows. Under the market approach, a market-based value is derived by relating multiples of revenue for a group of comparable public companies to the same measure for each reporting unit to estimate fair value. This valuation resulted in a Level 3 nonrecurring fair value measurement. See Note 5, Goodwill and Intangible Assets, for further information on the nature of the impairment. Marketable Debt Securities The following is a summary of marketable debt securities, which are included within the cash and cash equivalents, marketable securities, and other assets balances on the Consolidated Balance Sheets.
| October 3, 2025
(In millions) | Amortized Costs |  |  |  | Unrealized Losses |  | Fair Value
Commercial paper | $ | 2.0 |  |  |  |  | $ | — |  |  | $ | 2.0 |
Corporate notes/bonds | 4.1 |  |  |  |  | (0.1) |  |  | 4.0 |
U.S. treasury bills | 15.8 |  |  |  |  | — |  |  | 15.8 |
Government agencies | 2.0 |  |  |  |  | — |  |  | 2.0 |
Total marketable debt securities | $ | 23.9 |  |  |  |  | $ | (0.1) |  |  | $ | 23.8 |
| September 27, 2024
(In millions) | Amortized Costs |  | Unrealized Gains |  |  |  | Fair Value
Corporate notes/bonds | $ | 16.4 |  |  | $ | 0.1 |  |  |  |  | $ | 16.5 |
U.S. treasury bills | 6.1 |  |  | — |  |  |  |  | 6.1 |
Government agencies | 18.3 |  | — |  |  |  |  | 18.3
Certificates of deposit | 0.9 |  | — |  |  |  |  | 0.9
Total marketable debt securities | $ | 41.7 |  |  | $ | 0.1 |  |  |  |  | $ | 41.8 |
The contractual maturities of marketable debt securities as of October 3, 2025, are shown in the table below. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations.
| October 3, 2025
(In millions) | Amortized Costs |  | Fair Value
Contractual maturities: |  |  |
Due within one year | $ | 23.9 |  |  | $ | 23.8 |
Total marketable debt securities | $ | 23.9 |  |  | $ | 23.8 |
During the fiscal year ended October 3, 2025, there were no gross realized gains or losses from the sale of certain marketable debt securities that were reclassified out of accumulated other comprehensive loss. The following tables summarize the balance sheet locations for marketable debt securities:
| October 3, 2025
(In millions) | Commercial Paper |  | Corporate Notes/Bonds |  | Government Agencies |  | Treasury Bills |  |  |  | Total
Cash and cash equivalents | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 13.7 |  |  |  |  | $ | 13.7 |
Marketable securities | 2.0 |  |  | 4.0 |  |  | 2.0 |  |  | 2.1 |  |  |  |  | 10.1 |
Total marketable debt securities | $ | 2.0 |  |  | $ | 4.0 |  |  | $ | 2.0 |  |  | $ | 15.8 |  |  |  |  | $ | 23.8 |
|  |  | September 27, 2024
(In millions) |  |  | Corporate Notes/Bonds |  | Government Agencies |  | Treasury Bills |  | Certificates of Deposit | Total
Cash and cash equivalents |  |  | $ | — |  |  | $ | — |  |  | $ | 1.0 |  |  | $ | — |  | $ | 1.0 |
Marketable securities |  |  | 10.5 |  |  | 16.3 |  |  | 4.1 |  |  | 0.9 |  | 31.8 |
Other assets |  |  | 6.0 |  |  | 2.0 |  |  | 1.0 |  |  | — |  | 9.0 |
Total marketable debt securities |  |  | $ | 16.5 |  |  | $ | 18.3 |  |  | $ | 6.1 |  |  | $ | 0.9 |  | $ | 41.8 |

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 107 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 100 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2E -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 940 -SubTopic 820 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration